Professor, Pediatrics, University of California, Davis, School of Medicine
Pediatrics
Dr. Randi J. Hagerman, MD
|
|
Give Review
Randi Hagerman is an expert in the field of Pediatrics. She went to Stanford University School of Medicine. Stanford University School of Medicine is a top medical college. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine Randi Hagerman is a published doctor and has 99 publications published. The lastest was: 'Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism.' Randi J. Hagerman accepts Medicare payments and is listed with Medicare.gov.
Publications
- Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism.
- Treatment of the psychiatric problems associated with fragile X syndrome.
- Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome.
- The Fragile X Mouse is Cured, Now for the Patients.
- Translational research guided by animal studies in Fragile X Disorders.
- Serotonin dysregulation in Fragile X Syndrome: implications for treatment.
- Fragile X spectrum disorders.
- Participation of underrepresented minority children in clinical trials for Fragile X syndrome and other neurodevelopmental disorders.
- Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: A report of two cases.
- Parent-delivered touchscreen intervention for children with fragile X syndrome.
- Effects of labeling and pointing on object gaze in boys with fragile X syndrome: an eye-tracking study.
- Axonal neuropathy in female carriers of the fragile X premutation with fragile X-associated tremor ataxia syndrome.
- Immune mediated disorders in women with a fragile X expansion and FXTAS.
- ERP abnormalities elicited by word repetition in fragile X-associated tremor/ataxia syndrome (FXTAS) and amnestic MCI.
- The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery.
- Use of Emotional Cues for Lexical Learning: A Comparison of Autism Spectrum Disorder and Fragile X Syndrome.
- Association between macroorchidism and intelligence in FMR1 premutation carriers.
- Memantine Effects on Verbal Memory in Fragile X-associated Tremor/Ataxia Syndrome (FXTAS): a Double-blind Brain Potential Study.
- A family with two female siblings with compound heterozygous FMR1 premutation alleles.
- Emotion Potentiated Startle in Fragile X Syndrome.
- Translating molecular advances in fragile X syndrome into therapy: a review.
- Towards an Understanding of Neuropsychiatric Manifestations in Fragile X Premutation Carriers.
- Psychiatric symptoms in boys with fragile X syndrome: A comparison with nonsyndromic autism spectrum disorder.
- CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles.
- Symptoms of Autism in Males with Fragile X Syndrome: A Comparison to Nonsyndromic ASD Using Current ADI-R Scores.
- Psychological status in female carriers of premutation FMR1 allele showing a complex relationship with the size of CGG expansion.
- Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): Revisited.
- Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial.
- Abnormal Semantic Processing in Females with Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).
- Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carri...
- The challenges of clinical trials in fragile X syndrome.
- Electrocortical changes associated with minocycline treatment in fragile X syndrome.
- Fragile x-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles.
- Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.
- Fragile X syndrome: An aging perspective.
- Fragile X-associated tremor/ataxia syndrome (FXTAS) in grey zone carriers.
- A multimodal imaging analysis of subcortical gray matter in fragile X premutation carriers.
- Phenotypes of hypofrontality in older female fragile x premutation carriers.
- Receptive Vocabulary in Boys with Autism Spectrum Disorder: Cross-Sectional Developmental Trajectories.
- A Randomized Double-Blind, Placebo-Controlled Trial of Minocycline in Children and Adolescents with Fragile X Syndrome.
- Prevalence and risk of migraine headaches in adult fragile X premutation carriers.
- Epilepsy drives autism in neurodevelopmental disorders.
- Newborn screening and cascade testing for FMR1 mutations.
- Newborn, carrier, and early childhood screening recommendations for fragile X.
- Investigating Word Learning in Fragile X Syndrome: A Fast-Mapping Study.
- Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with fragile x syndrome.
- Influence of the fragile X mental retardation (FMR1) gene on the brain and working memory in men with normal FMR1 alleles.
- Sequencing the unsequenceable: Expanded CGG-repeat alleles of the fragile X gene.
- Treatment of neurodevelopmental disorders in adulthood.
- TARGETED TREATMENTS IN AUTISM AND FRAGILE X SYNDROME.
- Sertraline may improve language developmental trajectory in young children with fragile x syndrome: a retrospective chart review.
- Neural Substrates of Executive Dysfunction in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): a Brain Potential Study.
- Immune-mediated disorders among women carriers of fragile X premutation alleles.
- Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone.
- Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS.
- Hypertension in FMR1 premutation males with and without fragile X-associated tremor/ataxia syndrome (FXTAS).
- AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome.
- A fragile X sibship from a consanguineous family with a compound heterozygous female and partially methylated full mutation male.
- Fragile X Mental Retardation 1 (FMR1) Intron 1 Methylation in Blood Predicts Verbal Cognitive Impairment in Female Carriers of Expanded FMR1 Alleles: Evidence from a P...
- The Fragile X-associated Disorders: Time to Order Fragile X DNA Testing.
- Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder.
- Sleep apnea in fragile X premutation carriers with and without FXTAS.
- Investigation of amygdala volume in men with the fragile X premutation.
- Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice.
- Rare Intranuclear Inclusions in the Brains of 3 Older Adult Males With Fragile X Syndrome: Implications for the Spectrum of Fragile X-Associated Disorders.
- Diffusion tensor imaging in male premutation carriers of the fragile x mental retardation gene.
- Case report: Dystonia in a fragile X carrier.
- Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers.
- Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.
- Testing the FMR1 Promoter for Mosaicism in DNA Methylation among CpG Sites, Strands, and Cells in FMR1-Expressing Males with Fragile X Syndrome.
- Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome.
- Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine.
- Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures.
- Plasma cytokine profiles in Fragile X subjects: is there a role for cytokines in the pathogenesis?
- Shifting the paradigm for autism treatments.
- Fragile X: leading the way for targeted treatments in autism.
- Aging in fragile X syndrome.
- Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back.
- High-risk fragile x screening in Guatemala: use of a new blood spot polymerase chain reaction technique.
- Broad clinical involvement in a family affected by the fragile X premutation.
- Conversion disorder in women with the FMR1 premutation.
- Covariate adjusted correlation analysis with application to FMR1 premutation female carrier data.
- A quantitative ELISA assay for the fragile x mental retardation 1 protein.
- Prepulse inhibition in fragile X syndrome: feasibility, reliability, and implications for treatment.
- A review of fragile X premutation disorders: expanding the psychiatric perspective.
- The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome.
- Lifespan changes in working memory in fragile X premutation males.
- A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome.
- Advances in the treatment of fragile X syndrome.
- Fragile X: a family of disorders.
- Testing for fragile X gene mutations throughout the life span.
- Autism profiles of males with fragile X syndrome.
- Dementia in fragile X-associated tremor/ataxia syndrome (FXTAS): comparison with Alzheimer's disease.
- Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated Tremor/Ataxia syndrome...
- Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder.
- Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis.
- Reduced telomere length in older men with premutation alleles of the fragile X mental retardation 1 gene.
- Expanded clinical phenotype of women with the FMR1 premutation.
Schools
Stanford University School Of Medicine
Stanford
University Calif
Doctors Specialties
- Developmental-Behavioral Pediatrics
- Pediatrics
Accepted Insurances
Education
-
University of California San Diego -
Stanford University -
Stanford University School of Medicine
Hospital
-
University of California, Davis Medical Center
Drug Facts
| NPI NUMBER | 1659356020 | |
| NPPES Provider LastName | HAGERMAN | |
| NPPES Provider FirstName | RANDI | |
| NPPES Provider ZIPCode | 956166071 | |
| NPPES Provider State | CA | |
| Specialty Description | Pediatric Medicine | |
| Total Claim Count | 244.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1659356020 |
| Last Name Of The Provider | HAGERMAN |
| First Name Of The Provider | RANDI |
| View All |
Similar Doctors
|
Dr. Richard A. Gould, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Genevieve R. Palmer, MD |
|
|
Dr. Mary Beth J. Steinfeld, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert B. Broadhurst, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen Angkustsiri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robin L. Hansen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary J. Leigh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dian J. Davis, CPNP |